Monday, October 14, 2024

Fw: Ref.: (LML) 2024 winners Alliance Against Leprosy Prize"Case reports in leprosy - shared practice"

 

Leprosy Mailing List – October 14,  2024

 

Ref.:  (LML) 2024 winners Alliance Against Leprosy Prize"Case reports in leprosy - shared practice"

From:  Laila de Laguiche, Curitiba, Brazil


 

Dear Pieter,


As you know, the Alliance Against Leprosy ( AAL), together with the journal Hansenologia Internationalis: Leprosy and Other Infectious Diseases (HI), is promoting a special section in the HI journal entitled "Case reports in leprosy - shared practice", offering an annual prize to the three reports that obtain the best scores.


We are pleased to announce the 2024 winners and the editorial team share the understanding that scientific dissemination on leprosy through clinical case reports represents an opportunity to promote the rapid spread of knowledge.


We congratulate the winners and look forward to more articles, always stimulating!

 

Best regards,

 

Laila

Curitiba - Brazil

 

- 1º : 

Ulcerative type 1 lepra reaction in borderline tuberculoid leprosy: A rare presentation;

Autor: Sabha Mushtaq

https://periodicos.saude.sp.gov.br/hansenologia/article/view/40191/38202

 

ABSTRACT

 

Introduction:  

leprosy  is  a  chronic  infectious  disease  caused  by  Mycobacterium  leprae, characterized  by  a  wide  spectrum  of  clinical  presentations.  In  India,  borderline-tuberculoid  leprosy is the most common form encountered in  clinical  practice.

Type  1  lepra  reaction  in  borderline-tuberculoid leprosy usually presents as the development of erythema and/or edema in  pre-existing  skin  lesions. 

Ulceration  of  skin  lesions  in  type  1  lepra  reaction  is  uncommon  and  occurs  in  severe  reactions.  Objective:  to  report  an  unusual  presentation  of  borderline-tuberculoid leprosy with ulcerative type 1 lepra reaction in an immunocompetent patient.

 

Case description:

We present the case of a 65-year old  man  with  chief  complaints  of  ulcerated  plaque  over  his  left  thigh.  He  also  had  other  skin lesions suggestive of borderline-tuberculoid leprosy  over  his  trunk  and  limbs,  as  well  as enlarged,  mildly  tender  left  ulnar  and  lateral  popliteal  nerves.  A  slit  skin  smear  was negative, while a skin biopsy supported the diagnosis of borderline-tuberculoid leprosy.  The  patient  responded  to  multibacillary  multidrug  therapy  according  recommended  by  World  Health  Organization  and  tapering  doses  of  prednisolone,  with complete healing of the ulceration at six weeks follow-up.

 

Discussion:

Type 1 lepra reaction associated with borderline-tuberculoid leprosy usually presents with increased erythema and edema in pre-existing skin lesions. Ulceration in such skin lesions is not commonly seen except in cases with severe type 1 leprosy reactions. Administration of oral corticosteroids along with multibacillary multidrug therapy is the key to managing ulcerative type 1 lepra reaction. The ulceration heals rapidly with tapering doses of oral corticosteroids, limiting the duration of morbidity.

 

Final consideration:

The case emphasizes the need for dermatologists and leprologists to be aware of atypical presentations of leprosy reactions, ensuring timely diagnosis and effective management to achieve optimal patient outcomes.

 

 

 

- 2º : 

Concomitance of lepromatous leprosy and squamous cell carcinoma: case report;

Autors: Hugo Hatanaka, Bruno de Carvalho Dornelas, Pauline Dias Soares Girardi, Caio Oliveira Sena, Marcelo Campos Rocha, Isabela Maria Bernardes Goulart

 https://periodicos.saude.sp.gov.br/hansenologia/article/view/40198/38198

 

ABSTRACT

Introduction:

Leprosy is an endemic disease in Brazil, ranking second worldwide for  the  number  of  new  cases  diagnosed  yearly.  However,  late  diagnosis  of  this disease is still common. Objective: to alert health professionals to the importance  of  recognizing  the  insidious  signs  of  leprosy,  both  clinical  and  histopathological, even in the presence of other, more apparent alterations.

 

Presentation  and  discussion  of  the  case:  

A  man  with  skin  lesions  suggestive of squamous cell carcinoma.

On histological examination,  besides the  carcinoma,  there  were  aggregates  of  foamy  macrophages  full  of  acid-fast  bacilli  compatible  with  lepromatous  leprosy.  A  more  detailed  physical  examination by a multidisciplinary team from a national reference center also revealed skin with a diffuse infiltrated appearance and supraciliary madarosis, alterations  not  noticed  in  the  first  evaluation  at  another  service. 

 

Final considerations:  this  case  can  help  clinical  professionals  and  pathologists  pay  attention  to  skin  alterations  that  can  make  it  challenging  to  diagnose  leprosy, especially in endemic regions, to enable early diagnosis and reduce the disabilities related to the disease. 

 

 

- 3º : 

Quantitative PCR diagnostic value in monitoring a patient with leprosy: case report

Autors: Marcos Daniel Silva Pinheiro, Maisa Pereira Vieira, Daisy Cristina Monteiro dos Santos, Alexandre Castelo Branco, Lorena Bruna Pereira de Oliveira, Lucia Alves de Oliveira Fraga.

https://periodicos.saude.sp.gov.br/hansenologia/article/view/40201/38180

 

ABSTRACT

Introduction: 

Leprosy  is  a  chronic  granulomatous  disease  caused  by  Mycobacterium  leprae. Objective:  the  study  aims  to  report  the  follow-up  of a patient with leprosy, presenting a positive quantitative polymerase chain reaction (qPCR).

 

Case description:

The patient is a 53-year-old male residing in  the  rural  area  of  São  Geraldo  da  Piedade,  Minas  Gerais  State,  Brazil. 

In  2015,  the  patient  sought  care  at  the  Governador  Valadares  Municipal  Central  Polyclinic  and  was  referred  to  the  Dr.  Alexandre  Castelo  Branco  Reference Center for Endemic Diseases and Special Programs (CREDEN-PES) to  initiate  treatment. However,  he  did  not  adhere  to  the  therapy,  citing  difficulty accessing the center.

In 2017, he returned to CREDEN-PES, where he was examined  and  collected  material  for  bacilloscopy  and  qPCR.  The  bacilloscopy index (BI) result was zero and positive for qPCR. The patient was  referred  for  treatment  in  his  hometown  and  adhered  to  two  doses  of  multibacillary multidrug therapy (MB-MDT).

In 2021, he sought CREDEN-PES for new evaluations, resulting in BI = 1.5 and decreased plantar sensitivity.
He  began  a  unique  treatment  regimen  for  leprosy  (U-MDT). 

In  2023,  he  moved to Paraná State and recently reported his condition: regular health, altered  balance,  frequent  falls,  loss  of  strength  in  the  knees,  dry  skin,  and swelling behind the ear. The positivity of the qPCR reaction prompted the team to follow up with this patient, who initially did not adhere to the treatment.

 

Conclusion:

It is believed that using laboratory tools to assist and reinforce the diagnosis and treatment has contributed to more effective leprosy control

 

 

 


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/5a438035-1809-43c7-8344-a072cddd51ffn%40googlegroups.com.

No comments: